Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

NoAb BioDiscoveries and VigiCell in CNS services agreement
September 2010
SHARING OPTIONS:

TORONTO—NoAb BioDiscoveries of Mississauga, Canada, and VigiCell of Villejuif, France, announced Aug. 9 that they will collaborate and co-distribute each other 's complementary drug discovery services, geared toward central nervous system (CNS) targeted discovery research. NoAb BioDiscoveries will be the preferred distributor of VigiCell's in vitro Primary Rat Blood-Brain-Barrier (BBB) Model to predict drug candidate entrance to the brain. In return, VigiCell will represent NoAb's extensive expertise in the field of DMPK, and in particular, its suite of in vivo BBB penetration services, including serial CSF collection and microdialysis. Financial details of the partnership were not disclosed.


Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.